LYNDA FAY VOIGT

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. pmc Feasibility of including cellular telephone numbers in random digit dialing for epidemiologic case-control studies
    Lynda F Voigt
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer ResearchCenter, Seattle, Washington, USA
    Am J Epidemiol 173:118-26. 2011
  2. ncbi request reprint Characteristics of telephone survey respondents according to willingness to participate
    Lynda F Voigt
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 157:66-73. 2003
  3. ncbi request reprint Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease
    Jocelyn M Weiss
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Epidemiol 164:56-62. 2006
  4. ncbi request reprint Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy
    Jessica Chubak
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98195, USA
    Cancer Causes Control 18:1001-7. 2007
  5. pmc Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history
    Meira Epplein
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Epidemiol 168:563-70; discussion 571-6. 2008
  6. pmc Does pregnancy provide vaccine-like protection against rheumatoid arthritis?
    Katherine A Guthrie
    Clinical Statistics, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Arthritis Rheum 62:1842-8. 2010
  7. ncbi request reprint Do cases and controls matched on the first eight digits of their telephone number share geographic proximity and socioeconomic characteristics?
    Lynda F Voigt
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Ann Epidemiol 16:299-304. 2006
  8. ncbi request reprint Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years
    Janet R Daling
    Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 12:1175-81. 2003
  9. ncbi request reprint Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma
    Janet R Daling
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 95:2455-64. 2002
  10. ncbi request reprint Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer
    Jennifer A Doherty
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Obstet Gynecol 197:139.e1-7. 2007

Research Grants

Detail Information

Publications19

  1. pmc Feasibility of including cellular telephone numbers in random digit dialing for epidemiologic case-control studies
    Lynda F Voigt
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer ResearchCenter, Seattle, Washington, USA
    Am J Epidemiol 173:118-26. 2011
    ....
  2. ncbi request reprint Characteristics of telephone survey respondents according to willingness to participate
    Lynda F Voigt
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 157:66-73. 2003
    ..These findings suggest that additional effort expended in recruiting reluctant respondents may often result in more accurate estimates of population characteristics that are of interest in epidemiologic research...
  3. ncbi request reprint Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease
    Jocelyn M Weiss
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Epidemiol 164:56-62. 2006
    ..In general, a woman's risk of endometrial cancer appears to be influenced by similar risk factors regardless of disease severity...
  4. ncbi request reprint Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy
    Jessica Chubak
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98195, USA
    Cancer Causes Control 18:1001-7. 2007
    ..It is unknown whether postmenopausal unopposed estrogen users are better off, in terms of endometrial cancer risk, switching to a combined estrogen-progestin regimen or stopping hormone use altogether...
  5. pmc Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history
    Meira Epplein
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Epidemiol 168:563-70; discussion 571-6. 2008
    ..Whether these risk factors predispose women to cancer simply by increasing EH incidence or continue to augment cancer risk even after EH is present is currently unknown...
  6. pmc Does pregnancy provide vaccine-like protection against rheumatoid arthritis?
    Katherine A Guthrie
    Clinical Statistics, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Arthritis Rheum 62:1842-8. 2010
    ..Fetal cells acquired during pregnancy provide a potential explanation for modulation of RA risk by pregnancy. The present study was undertaken to examine the effect of parity on RA risk...
  7. ncbi request reprint Do cases and controls matched on the first eight digits of their telephone number share geographic proximity and socioeconomic characteristics?
    Lynda F Voigt
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Ann Epidemiol 16:299-304. 2006
    ..The aim of this study is to assess the geographic proximity of cases and controls who share the same "stem" of their telephone number (area code, prefix, and next two digits) and compare their socioeconomic characteristics...
  8. ncbi request reprint Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years
    Janet R Daling
    Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 12:1175-81. 2003
    ....
  9. ncbi request reprint Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma
    Janet R Daling
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 95:2455-64. 2002
    ..However, the use of combined (estrogen and progestin) hormone replacement therapy (CHRT) also has increased during the last decade and may account in part for the increase in invasive lobular breast carcinoma...
  10. ncbi request reprint Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer
    Jennifer A Doherty
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Obstet Gynecol 197:139.e1-7. 2007
    ....
  11. doi request reprint Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas
    Christopher I Li
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 17:43-50. 2008
    ..Further studies focusing on the etiology of lobular carcinomas are needed...
  12. ncbi request reprint Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer
    Susan D Reed
    Department of Obstetrics and Gynecology, Division of Public Health Sciences, University of Washington, 325 9th Avenue, Seattle, WA 98115, USA
    Am J Obstet Gynecol 191:1146-51. 2004
    ..The pattern and number of days per month that progestin is given in postmenopausal combined hormone therapy appears to affect endometrial cancer risk. We assessed the impact of progestin dose on this risk...
  13. pmc Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy
    Meira Epplein
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA
    Ann Epidemiol 19:1-7. 2009
    ..We sought to examine the relationship between recent use of oral contraceptives and hormone therapy and endometrial hyperplasia (EH) risk...
  14. ncbi request reprint Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors
    Babette S Saltzman
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 167:607-14. 2008
    ..These results support the hypothesis that type 2 diabetes is associated with endometrial cancer irrespective of the presence of other risk factors for this disease, except possibly hypertension and extreme obesity...
  15. ncbi request reprint Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer
    Jennifer A Doherty
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, P O Box 19024 M4 C308, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 14:357-66. 2005
    ....
  16. pmc Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy
    Susan D Reed
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington 98115, USA
    Obstet Gynecol 116:365-73. 2010
    ..We evaluated women with complex and atypical endometrial hyperplasia, comparing those prescribed progestin with those not prescribed progestin...
  17. ncbi request reprint Racial variation in the incidence of squamous cell carcinoma of the bladder in the United States
    Michael P Porter
    Department of Urology, College of Medicine and Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, USA
    J Urol 168:1960-3. 2002
    ..We determined the incidence of squamous cell carcinoma of the bladder according to race in the United States...
  18. pmc Diagnosing endometrial hyperplasia: why is it so difficult to agree?
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center, Seattle, WA, USA
    Am J Surg Pathol 32:691-8. 2008
    ..Although obtaining additional tissue may increase diagnostic reproducibility, differences in interpretation of key histologic features like cytologic atypia remain major factors contributing to diagnostic disagreement...
  19. ncbi request reprint Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor
    Chu Chen
    Program in Epidemiology, Fred Hutchinson Cancer Research Center, WA, USA
    Cancer Epidemiol Biomarkers Prev 15:2461-6. 2006
    ..Our observation that men who do not carry two copies of the IGF-IR (AGG)7 allele are at increased risk of prostate cancer merits further investigation...

Research Grants2